GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human sirtuin 2 in complex with a selective inhibitor

Analyse Crystal structure of human sirtuin 2 in complex with a selective inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5Y5N
Type
protein
Length
288 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacetylase sirtuin-2
EC
3.5.1.-
UniProt
Q8IXJ6
Ligands
8NO, ZN
Pockets
2 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-)protein28842% helix, 17% strandQ8IXJ6

Ligands and binding sites

  • 8NO · 2-[[3-(2-phenylethoxy)phenyl]amino]benzamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12710.760.88428NO
21480.450.7624empty

Compared structures

  • 5Y5N · Crystal structure of human Sirtuin 2 in complex with a selective inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.